Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Common Equity (2016 - 2026)

Healthequity has reported Common Equity over the past 13 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Common Equity changed 0.36% year-over-year to $2.1 billion; the TTM value through Jan 2026 reached $2.1 billion, changed 0.36%, while the annual FY2026 figure was $2.1 billion, 0.36% changed from the prior year.
  • Common Equity for Q1 2026 was $2.1 billion at Healthequity, down from $2.1 billion in the prior quarter.
  • Over five years, Common Equity peaked at $2.2 billion in Q3 2024 and troughed at $1.9 billion in Q1 2022.
  • A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: skyrocketed 34.37% in 2022 and later fell 0.49% in 2025.
  • Year by year, Common Equity stood at $1.9 billion in 2022, then increased by 5.57% to $2.0 billion in 2023, then increased by 6.88% to $2.1 billion in 2024, then rose by 0.44% to $2.1 billion in 2025, then dropped by 1.26% to $2.1 billion in 2026.
  • Business Quant data shows Common Equity for HQY at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.